| __timestamp | Evotec SE | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17990000 | 49315000 |
| Thursday, January 1, 2015 | 25166000 | 75043000 |
| Friday, January 1, 2016 | 27013000 | 83749000 |
| Sunday, January 1, 2017 | 42383000 | 122682000 |
| Monday, January 1, 2018 | 57012000 | 207761000 |
| Tuesday, January 1, 2019 | 66546000 | 284812000 |
| Wednesday, January 1, 2020 | 77238000 | 317875000 |
| Friday, January 1, 2021 | 105445000 | 282660000 |
| Saturday, January 1, 2022 | 156190000 | 451421000 |
| Sunday, January 1, 2023 | 169610000 | 481871000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Sarepta Therapeutics, Inc. and Evotec SE have taken different paths in optimizing these costs. From 2014 to 2023, Sarepta's SG&A expenses surged by over 870%, reflecting its aggressive expansion strategy. In contrast, Evotec SE maintained a more conservative growth, with a 840% increase in the same period. By 2023, Sarepta's SG&A expenses were nearly three times higher than Evotec's, highlighting its larger operational scale. However, Evotec's steady approach may suggest a more sustainable cost management strategy. As these companies continue to evolve, their ability to balance growth with cost efficiency will be pivotal in determining their long-term success.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Sarepta Therapeutics, Inc.
AbbVie Inc. vs Evotec SE: SG&A Expense Trends
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Sarepta Therapeutics, Inc.
Selling, General, and Administrative Costs: Bio-Techne Corporation vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Sarepta Therapeutics, Inc. and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Evotec SE
Grifols, S.A. or Evotec SE: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: CRISPR Therapeutics AG vs Evotec SE
Comparing SG&A Expenses: Amicus Therapeutics, Inc. vs Evotec SE Trends and Insights
Ligand Pharmaceuticals Incorporated vs Evotec SE: SG&A Expense Trends
Selling, General, and Administrative Costs: Evotec SE vs Novavax, Inc.